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Abstract Kinetics of Ca 2+ release by adenophostin, a novel ag- 
onist of inositol 1,4,5-trisphosphate (IP3) receptor, in the purified 
and reconstituted IP 3 receptor type 1 (IP3R1) was investigated 
using the fluorescent Ca z+ indicator fluo-3. Submaximal concen- 
trations of adenophostin caused quantal Ca 2÷ release from the 
purified IP3R1 as IP 3 did. Adenophostin-induced Ca2+ release by 
the purified IP3R1 exhibited a high positive cooperativity 
(nil = 3.9 + 0.2, ECso = 11 nM), whereas the IP3-induced Ca 2+ 
release exhibited a moderate one (nil = 1.8 + 0.1, ECso = 100 
nM). Inhibition of [3H]IP3 binding to the purified IP3RI by aden- 
ophostin exhibited a positive cooperativity (nil = 1.9, K i = 10 
nM), whereas IP3 did not (nil = 1.1, K i = 41 nM). 
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I. Introduction 
Inositol 1,4,5-trisphosphate (IP3), a second messenger de- 
rived from the hydrolysis of phosphatidylinositol 4,5-bis- 
phosphate, is responsible for Ca 2+ release from intracellular 
calcium stores [1]. IP 3 receptor (IP3R) is an IP3-activated Ca 2+ 
release channel and plays a crucial role in Ca 2. signaling in a 
variety of cell functions. Thus, kinetic studies of IP3-induced 
Ca 2+ release (IICR) are fundamental for elucidating the mech- 
anisms underlying intracellular dynamics of Ca 2+ signaling. Re- 
cent molecular cloning studies have revealed that there are at 
least three types of the IP3R from distinct genes [2-4]. Differ- 
ences in the primary sequences, especially in the modulator 
domains including putative phosphorylation a d modulator- 
binding sites, among these IP3R types suggest that there may 
be differences in Ca 2÷ release properties of each receptor type 
[5]. It is now known that these different IP3R types often coexist 
in single cells [6]. Therefore, to study the kinetics of IICR, each 
IP3R type should be investigated independently. This would 
allow us to relate differences in the structure of each IP3R type 
to differences in the Ca 2+ release kinetics. 
*Corresponding author. Fax: (81) (3) 5449-5420. 
Abbreviations." 1P3, D-myo-inositol 1,4,5-trisphosphate; IP3R, IP 3 recep- 
tor; IP3RI, IP3R type 1; CHAPS, 3-[(3-cholamidopropyl)dimethyl- 
ammonio]-l-propanesulfonic acid;HEPES, N-(2-hydroxyethyl)piperi- 
zine-N'-2-ethanesulfonic acid. 
To understand the mechanisms and roles of IICR underlying 
intracellular Ca 2+ signalling, development of specific agonists 
and antagonists with high affinity for IP3 R are needed. There 
are few pharmacological reagents available for analysis of 
IICR. No specific antagonist for IICR is known, but heparin 
inhibits IP3 binding to the IP3R in a non-specific manner. On 
the other hand, novel agonists, adenophostin A and B, have 
been isolated recently as fungal products [7]. Adenophostin s 
the most potent agonist, which has higher binding affinity and 
Ca z÷ release activity than the native ligand, IP3. 
Recently, we have investigated the kinetics of IP3R type 1 
(IP3R1)-mediated IICR using the fluorescent Ca 2+ indicator 
fluo-3, and reported that the IP3Rl-mediated I1CR exhibited 
a positive cooperativity (nil = 1.8), quantal Ca 2+ release and 
biphasic nature (Hirota et al., submitted). In the present study, 
to define the properties of the new agonist adenophostin, we 
have investigated the kinetics of Ca z+ release induced by aden- 
ophostin (adenophostin B) and compared the kinetics with that 
by IP3 in terms of the cooperativity, quantal and biphasic na- 
ture of IP3Rl-mediated Ca 2+ release. 
2. Materials and methods 
2.1. Materials" 
IP3, fluo-3 and CHAPS were obtained from Dojindo Laboratories 
(Kumamoto, Japan), Chelex-100 from Bio-Rad, DTPA-conjugated 
polymetal-sponge from Molecular Probes, phosphatidylcholine, 
phosphatidylserine a dcholesterol from Avanti Polar-Lipids, INC. All 
other eagents used were of analytical grade or the highest grade avail- 
able. Adenophostin (adenophostin B) was isolated from the culture 
broth of Penicillium Brevicompactum SANK 11991 [8]. 
2.2. Purification of lP~R type 1 (IP~R1) 
IP3R1 was purified type-specifically from mouse cerebellar micro- 
somal fraction by using an immunoaffinity column conjugated with an 
anti-pep 6antibody, a polyclonal ntibody against IP3R1 C-terminus, 
as reported previously [9]. 
2.3. Reconstitution f the purified IP3R1 
The purified IP3R 1 was reconstituted into lipid vesicles by the dialysis 
method. Phosphatidylcholine, pbosphatidylserine a d cholesterol dis- 
solved in chloroform were mixed to give a concentration f 3, 1 and 0.8 
mg/ml, respectively. The lipid mixture was dried to a thin film under 
a stream of nitrogen gas and then under vacuum. The lipid film was 
suspended at 2 mg/ml in buffer A (100 mM KC1, 1 mM 2-mercaptoetha- 
nol, 10 mM HEPES KOH (pH 7.4) and 4 mM CaCI2) containing 1% 
CHAPS. The immunoaffinity purified IP3R 1 was concentrated by using 
Centriprep 100 (Amicon) to give a protein concentration f 100 pg/ml. 
The concentrated IP3RI solution was mixed with buffer A containing 
lipids and detergent togive final IP3R1, lipids and CHAPS of 50/~g/ml, 
0.5 mg/ml and 1%, respectively. After 20 min incubation on ice with 
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Fig. 1. Typical profile of Ca :+ release by adenophostin i  the purified 
and reconstituted IP3R 1. Changes of fluorescence of the Ca ~+ indicator 
fluo-3 were recorded after injection of 15 nM adenophostin. Adeno- 
phostin-induced Ca -'÷ release from the liposomes was followed by a 
constant leakage of Ca 2÷ (the dotted line). (B) The net Ca 2÷ release was 
obtained by extrapolating and subtracting the constant Ca ~+ leakage 
from the profile. The profile of net Ca ~÷ release was found to be well 
fitted by a biexponential (the solid line) with the fast and slow rate 
constants. 
occasional gentle stirring, the IP3R l-lipid mixtures were dialyzed for 72 
hours against 8changes of a 500-fold volume xcess of buffer A at 4 ° C. 
The resulting proteoliposomes (IP~R1 in lipid vesicles) were pelleted by 
centrifugation at 100,000 × g for 30 rain at 2°C, and were washed with 
buffer B (buffer A with 10 pM fluo-3 but no Ca 2+) twice, and were 
resuspended with buffer B to the same volume used before dialysis. 
After incubation for 10 min at 25°C, the resuspended proteoliposomes 
were passed over Chelex-100 to remove xtravesicular Ca ~+, and then 
were used for Ca 2+ release assay. 
2.4. Measurements of adenophostin- and IP~-induced Ca 2÷ release 
Adenophostin- and IP3-induced Ca z+ efflux from the prote- 
oliposomes were measured by monitoring the fluorescence changes of 
fluo-3. Briefly, fluorometric measurements of Ca 2÷ release were per- 
formed by using an F-2000 fluorometer (Hitachi Inc.). The excitation 
and emission wavelengths were 500 and 525 nm, respectively, with 10 
nm bandpass. Measurements were made at 25°C in a 0.5 x 0.5 cm 
quartz cuvette containing 0.4 ml of the proteoliposome solution with 
continuous-stirring by a Teflon stir bar. Ca ~+ release was monitored 
after addition of 2 pl adenophostin or IP3 to give the desired concentra- 
tions. The data was acquired every 200 ms. The fluorescent intensities 
of fluo-3 were calibrated to free Ca z+ concentrations u ing a Ca ~+ 
calibration kit with modification of pH to 7.4 (Molecular Probes). The 
calibration curve gave the dissociation constant of fluo-3 for Ca ~+ of 
170 nM, which was used to estimate the free and total Ca 2÷ concentra- 
tions. To exclude the possibility of feedback regulation by the released 
Ca 2+, we used 10 pM fluo-3, which was high enough to chelate the 
released Ca ,-÷ and to keep deviations ofextravesicular free Ca 2+ concen- 
trat ion within 10-30 nM. Extravesicular free Ca ~÷ concentrations prior 
to addition of adenophostin or IP 3 were approximately 100 nM 
throughout the experiments. 
2.5. [~H]IP~ binding assay 
[3H]IP 3 binding assay was performed by the polyethylene glycol pre- 
cipitation method [10]. 0.5/.tg of the purified IP3R1 was incubated in 
50/.tl of the solution containing 50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 
1 mM 2-mercaptoethanol, 9.6 nM [~H]IP3, and either adenophostin or
cold IP3, for 10 min at 4°C. Non-specific binding was measured in the 
presence of 100 nM adenophostin or 2/~M IP3. 
3. Results and discussion 
3.1. Measurement of  Ca 2+ release induced by adenophostin and 
1P, 
In this study, we have investigated the kinetics of adeno- 
phostin- and IP3-induced Ca 2+ release by a single member of 
the IP3R family in artificial membrane vesicles, thereby exclud- 
ing the possibilities of modulat ion of Ca z÷ release kinetics by 
factors such as IP3 metabolism, Ca ~+ pumping activity, involve- 
ment of molecules ensing changes in Ca 2+ concentrat ion and 
heterogeneity of IP3R types. As we used high enough concen- 
trat ion of fluo-3 to keep extravesicular free Ca 2+ concentrat ion 
almost constant as described in section 2, we could expect to 
rule out the possibility of the feedback regulation of the subse- 
quent Ca z+ release activity by changes of extravesicular f ee 
Ca ~+ concentrations, which have been observed in permeabil- 
ized cell systems [11,12] and microsome assays [13,14]. 
Fig. 1 shows a typical profile of adenophost in- induced Ca ~+ 
release by the immunoaffinity-purif ied IP3R 1 reconstituted into 
lipid vesicles. 15 nM adenophost in- induced Ca ~+ release from 
the liposomes followed a constant leakage of Ca 2+ (Fig. 1A), 
which was linear over the time range of the measurements, 
confirming that adenophost in is a true agonist of IP3R1. The 
net Ca :+ release (Fig. 1 B) was obtained by extrapolating and 
subtracting the constant Ca 2+ leakage (Fig. 1A) from the pro- 
file. The net I ICR could not be fitted by a single exponen- 
tial but was found to be a biexponential (Fig. 1B) with the fast 
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Fig. 2. Time course of Ca 2+ release following the injection of different 
concentrations of agonist. Adenophostin- and IP3-induced Ca 2÷ release 
at different concentrations of IP3 were performed on a single batch of 
proteoliposomes. (A) [adenophostin] = 100 nM (a), 50 nM (b), 11 nM 
(c), 9 nM (d), 7 nM (e), 5 nM (f). (B) [IP3] = 5/.tM (a). 500 nM (b), 200 
nM (c), 70 nM (d) 40 nM (e) and 20 nM (f). 
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Fig. 3. The amounts of released Ca 2÷ plotted as a function of concentra- 
tions of adenophostin (o) and IP3 (•). The amounts of released Ca 2+ 
were plotted as a function of adenophostin a d IP 3 concentrations. The 
data were normalized to the amplitude for 100 nM adenophostin a d 
5.0 #M IP 3 (values are mean + S.D., n = 3~). 
and slow rate constants (kfa~-- 0.63 + 0.02 s -~ (76 + I%), 
k~ow = 0.050 + 0.002 s -~ (24 + 1%)), indicating that in response 
to adenophostin the purified IP3R1 has two states to release 
Ca 2+. 
A[Ca2+]tot,l = T(1 - Afast" e -/'-fast't - Aslow" e -kSl°w') (1) 
where T represents a total amount of released Ca 2+, A is ampli- 
tude of the fast and slow components (%) (Ar,~t+A~ow = 100%), 
k is rate constant (s -1) and t is time (s). 
3.2. Kinetics of adenophostin- and 1P3-induced Ca 2+ release 
Different concentrations of adenophostin and IP3 were 
added to obtain dose-response curves. Fig. 2A and B show 
typical time courses of Ca 2÷ release by adenophostin and IP3, 
respectively, from the same batch of proteoliposomes. These 
profiles were found to be biexponential. Submaximal concen- 
trations of adenophostin and IP3 caused partial Ca 2+ release, 
and rates of Ca 2+ release were dependent on the adenophostin 
and IP 3 concentrations. After full Ca =+ release by maximal 
concentrations of adenophostin and IP 3, no additional Ca =+ 
release was evoked by additions of IP 3 and adenophostin, re- 
spectively (data not shown). The amounts of released Ca 2+ by 
maximal doses of adenophostin and IP3 were identical. 
Relative amounts of released Ca 2+ at various concentrations 
of adenophostin and IP3 are shown in Fig. 3 (n = 34) .  The 
amount of released Ca 2+ increased as a function of adeno- 
phostin and IP3 concentrations, indicating that adenophostin 
is capable of producing the quantal response of Ca 2+ release by 
the purified IP3R1 as IP3 did. These results suggest hat the 
quantal Ca 2+ release is not a unique phenomenon to the native 
ligand, IP3, but is an intrinsic property of IP3R1. 
The initial rates of Ca 2+ release varied with adenophostin a d 
IP3 concentrations and saturated above 20 nM adenophostin 
and 1 #M IP3 (Fig. 4A). Half-maximal initial rates of Ca 2+ 
release occurred at 11 nM adenophostin and 100 nM IP 3, indi- 
cating that adenophostin was approximately 10-fold more po- 
tent than the native ligand, IP3, in Ca =+ releasing activity. How- 
ever, in the previous experiments using rat cerebellar micro- 
somes, adenophostin was 100-fold more potent than IP3 [7]. 
The difference in the potencies of Ca 2+ releasing activity ob- 
tained may be due to different assay systems used. 
3.3. Cooperativity of ligand binding and Ca 2. releasing activity 
of  IP3R1 by adenophostin and IP 3 
The extent of cooperativity of Ca =+ release is an important 
and fundamental issue for understanding the channel opening 
mechanism. In previous reports, there is controversy about the 
cooperativity of IICR, i.e. no cooperativity [13,14] or positive 
cooperativity (nil----2) [15,16] (n,  = 4) [17] has been reported. 
We determined the degree of cooperativity of IP3Rl-mediated 
Ca 2+ release by Hill plotting using initial rates of Ca 2+ release 
(Fig. 4B). The slopes in the Hill plots over the range of submax- 
imal concentrations of adenophostin (5 15 nM) and IP3 (20- 
200 nM) were 3.9 + 0.2 and 1.8 + 0.1, respectively, indicating 
that adenophostin-induced Ca 2+ release by the purified IP3R1 
exhibited a high positive cooperativity (nH=3.9+0.2) ,  
whereas the IP3-induced Ca 2+ release xhibited a moderate one 
(n,  = 1.8 + 0.1). The results uggest that at least four molecules 
of adenophostin or two molecules of IP3 per one IP3Rl-chan- 
nel are needed for Ca 2+ release. 
As both adenophostin- and IP3-induced Ca 2+ release consist 
of two sequential events, i.e. ligand-binding and channel open- 
ing, we have studied the cooperativity of ligand binding to the 
purified IP3RI. Fig. 5 shows inhibition curves of [3H]IP3 bind- 
ing to the purified IP3RI by various concentrations of adeno- 
phostin and IP3. Adenophostin i hibited [3H]IP 3 binding to the 
purified IP3R1 with higher potency (ICs0 = 19 nM) than IP3 
(ICs0 = 76 nM). The apparent inhibition constants (Ki) for 
adenophostin and IP3 were calculated to be 10 nM and 41 nM, 
respectively, using following equation. 
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Fig. 5. Inhibition of [3H]IP3 binding to the purified IP3RI by adeno- 
phostin (e) and IP3 (1). The [3H]|P 3 binding assay was carried out as 
described in section 2. (A) Displacement curves of [3H]IP3 binding in 
the presence of adenophostin (e) and IP 3 (,1). (B) Hill plot of inhibition 
of [3H]IP3 binding (Y I% control) by adenophostin (e) and IP3 (m). 
Measurements were duplicated. 
K, = (ICso/(1 + C/Kd) ) (2) 
where C represents a total concentration of [3H]IP3 (C = 9.6 
nM) and Kd is dissociation constant of [3H]IP3 binding (Ka = 11 
nM). 
The affinities of adenophostin and IP 3 to the purified IP3R1 
were well correlated to their Ca 2+ releasing activities. Hill coef- 
ficiencies of the displacement curves of [3H]IP 3 binding in the 
presence of adenophostin a d IP 3 were 1.9 and 1.1, respectively 
(Fig. 5B), indicating that in terms of binding to IP3R1 adeno- 
phostin exhibited a positive cooperativity, whereas IP 3 did not. 
These results demonstrated that the difference in the coopera- 
tivity of ligand-binding may result in the difference in the coop- 
erativity of Ca 2+ releasing between both agonists. 
3.4. Analysis of biphastic and quantal natures of adenophostin- 
induced Cd + release 
To analyze the kinetic features of adenophostin-induced 
Ca 2+ release in detail, we attempted to curve fit the profiles. All 
profiles of Ca 2+ release consisted of the sum of two single 
exponentials as IP 3 did. The rate constants of the fast and slow 
components differed by a factor of about 10 (Fig. 6A) similar 
to those of IP3-induced Ca 2÷ release (Fig. 6B). Both the fast and 
slow rate constants were dependent on the concentrations of
adenophostin and IP3. The amplitudes of both states (Af,~t and 
A~ow) derived from the curve fitting were plotted as a function 
of the concentrations of adenophostin and IP3 (Fig. 6C and D). 
The amplitudes of the fast component increased as the concen- 
tration of adenophostin and IP3 increased, whereas those of the 
slow components decreased. Considering these amplitudes with 
the amounts of total released Ca 2+, the amounts of released 
Ca 2+ by the fast and slow phases were then calculated. The 
amounts of released Ca 2. by the fast and slow components 
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Fig. 7. The amounts of released Ca 2+ by the fast and slow components 
of adenophostin-induced Ca 2+release (o = fast; and © = slow) and IP3- 
induced Ca 2÷ release (m = fast; and [] = slow). The amounts of total 
released Ca 2+ (Fig. 3) and the amplitude of the two components of
adenophostin-induced Ca -'+ release (Fig. 6C) and IP3-induced Ca 2+ re- 
lease (Fig. 6D) allowed us to calculate the amounts of released Ca 2+ by 
the fast (the closed symbols) and slow (the open symbols) components 
(values are mean + S.D., n = 3-4). 
relative to that of 100 nM adenophostin and 5/zM IP3 were 
plotted as the function of the concentrations of adenophostin 
and IP 3 (Fig. 7A and B). The amounts of released Ca 2+ by the 
fast component increased as a function of the concentrations 
of adenophostin and IP3, whereas the amounts of the slow 
component were almost constant, i.e. already saturated, over 
the concentrations of adenophostin and IP3 examined. These 
results suggest hat the fast component is kinetically the state 
of low affinity for both adenophostin and IP 3 and high perme- 
ability of Ca 2÷, but the slow component is of high affinity and 
low permeability. Since the fast phase of Ca 2+ release increases 
with increasing IP3 concentrations and the slow phase remains 
constant, our data demonstrates that the fast phase is not only 
the determinant of the amount of Ca 2÷ release but also respon- 
sible for the quantal Ca 2+ release. In the [3H]IP3 binding exper- 
iments using IP3, we detected single state of IP3R1, although 
two states were observed in Ca 2+ releasing experiments. The 
difference of numbers of the state of 1P3RI may be due to the 
difference in experimental conditions, i.e. pH, temperature and 
buffer compositions. 
Recently, heterogeneity of IP3R densities in pools, which had 
equal sensitivity to IP 3, was reported to be responsible for 
biphasic Ca 2+ release [18]. We wish to discuss such possibility. 
If this is the reason for biphasic nature of IICR, the amplitudes 
of the fast and slow components in the curve fitting should be 
independent to the IP3 concentrations, and the ratio of the 
amounts of released Ca 2+ by the fast and slow components must 
be constant. Because in such an assumption, the amplitudes 
and the ratio of the amounts of released Ca 2+ should reflect he 
distribution of such heterogeneity, i.e. the amplitudes and the 
amounts of the released Ca 2÷ by the fast and slow phases reflect 
numbers of IP3-sensitive Ca 2+ pools with high and low density 
of IP3R, respectively. However, in our experiments, the ampli- 
tudes of the fast and slow components, and the ratio of the total 
released Ca 2+ were dependent on IP3 concentrations, indicating 
that the biphasic nature of Ca 2+ release was not due to such 
heterogeneity of receptor density. A possibility of heterogeneity 
in the size of individual Ca 2+ pools was also excluded by the 
same reasons and by the direct observation using electron mi- 
croscopy. The average diameter of the liposome was 170 + 50 
nm (n = 300) and the distribution of the size was represented 
in single peak (data not shown). 
Here, we have demonstrated that adenophostin, a novel ag- 
onist of the IP3R, is capable of producing the quantal response 
of Ca 2+ release as IP3 did, but exhibited ifferent positive coop- 
erativity in ligand-binding steps and high positive cooperativity 
in Ca 2+ release from those of IP 3. The present study has also 
demonstrated that the purified IP3R1 has two states with differ- 
ent affinity for both adenophostin and IP3, i.e. a low affinity 
and high affinity state. This could arise from alternative splicing 
leading to the production of variants of IP3R1. Alternatively, 
there may be two different states of a single IP3R due to ligand- 
dependent inactivation or interconversion. 
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